W.O.M. World of Medicine AG

10.4% growth in sales the first nine months of 2008

2008 earnings goal confirmed/ -------------------------------------------------------------------------------- ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- balance/9-Month Report 2008 Berlin (euro adhoc) - Sales of medical device manufacturer WORLD OF MEDICINE grew in the first nine months of 2008 by 10.4% to TEUR27,769. Pre-tax sales yield equaled last year's figure of 15.6%. "The Company is positioned within the corridor that will enable us to achieve the earnings goal for 2008: A pre-tax sales yield of 11%," says Peter P. Wiest, CEO. "However, we are seeing signs of a further slowdown, particularly in the US market, due to the current financial crisis. In view of the consequent risks to projected growth and to our business, we currently anticipate that the Group will fall slightly short of the 2008 sales target - an increase equal to 7%." For the medium term, WORLD OF MEDICINE has firmly secured its position as the global market leader in a significant area of Minimally Invasive Surgery through strategically important projects and a global agreement with a US-based major customer. Earnings per share in the first nine months of 2008 equaled EUR 0.34. Last year,one-time proceeds from the sale of the former subsidiary, IB Laser, were reported. | |9M/2008 |9M/2007 |Change ||Sales |TEUR27,769 |TEUR25,142 |+ 10.4% | |EBT |TEUR4,323 |TEUR3,927 |+ 10.1% | |Pre-tax sales yield|15.6% |15.6% |+/- 0 % | |Earnings per share |EUR 0.34 |EUR 0.54 |- 37.0% (adjusted for | | | |one-time effect on income: EUR 0.43) | | The entire Quarterly Financial Report for the first 9 months of 2008 is available at: www.world-of-medicine.com/wsc/pdf/wom/en/qr_9monthreport_2008_wom.pdf WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS for short. This approach includes safe and gentle surgical procedures conducted through keyhole or puncture incisions, in place of major incisions. The Company is the global market leader in a niche of this future market. end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: W.O.M. World of Medicine AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Stefanie Gehrke Tel.: +49 (0)30 399 81 566 E-Mail: stefanie.gehrke@womcorp.com Branche: Pharmaceuticals ISIN: DE0006637390 WKN: 663739 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse München / free trade

Das könnte Sie auch interessieren: